Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.Peer reviewedPublisher PD
BACKGROUND and OBJECTIVE: To evaluate the change in drusen volume following treatment with eculizuma...
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal thera...
PURPOSE: To determine the safety and efficacy of AL-8309B (tandospirone) in the management of patien...
INTRODUCTION Geographic atrophy (GA) is a progressive form of age-related macular degeneration (A...
Purpose: To evaluate the effect of eculizumab, a systemic inhibitor of complement component (C5), on...
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness among older adul...
IMPORTANCE Geographic atrophy (GA) secondary to age-related macular degeneration is a leading cause ...
IMPORTANCE: Geographic atrophy (GA) secondary to age-related macular degeneration is a leading cause...
To evaluate clinical characteristics of eyes in which investigator-determined new-onset exudative ag...
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal ther...
William Rhoades, Drew Dickson, Diana V Do Truhlsen Eye Institute, Department of Ophthalmology and V...
Age-related macular degeneration (AMD) is a leading cause of blindness in older adults. One of the s...
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed c...
BACKGROUND: Age-related macular degeneration (AMD) is a common retinal disease in older people. In E...
Age-related macular degeneration (AMD) is a multifactorial disease and a leading cause of vision imp...
BACKGROUND and OBJECTIVE: To evaluate the change in drusen volume following treatment with eculizuma...
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal thera...
PURPOSE: To determine the safety and efficacy of AL-8309B (tandospirone) in the management of patien...
INTRODUCTION Geographic atrophy (GA) is a progressive form of age-related macular degeneration (A...
Purpose: To evaluate the effect of eculizumab, a systemic inhibitor of complement component (C5), on...
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness among older adul...
IMPORTANCE Geographic atrophy (GA) secondary to age-related macular degeneration is a leading cause ...
IMPORTANCE: Geographic atrophy (GA) secondary to age-related macular degeneration is a leading cause...
To evaluate clinical characteristics of eyes in which investigator-determined new-onset exudative ag...
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal ther...
William Rhoades, Drew Dickson, Diana V Do Truhlsen Eye Institute, Department of Ophthalmology and V...
Age-related macular degeneration (AMD) is a leading cause of blindness in older adults. One of the s...
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed c...
BACKGROUND: Age-related macular degeneration (AMD) is a common retinal disease in older people. In E...
Age-related macular degeneration (AMD) is a multifactorial disease and a leading cause of vision imp...
BACKGROUND and OBJECTIVE: To evaluate the change in drusen volume following treatment with eculizuma...
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal thera...
PURPOSE: To determine the safety and efficacy of AL-8309B (tandospirone) in the management of patien...